Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ITF2357 + Mechlorethamine in Relapsed/Refractory Hodgkin's Lymphoma
NCT00792467Phase 2Completed
- Sponsor
- Italfarmaco
- Start
- Feb 2008
- Primary completion
- Jul 2010
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of givinostat in Hodgkin lymphoma (HL), sponsored by Italfarmaco. Started Feb 2008; status: completed.
02
Drugs
givinostat
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00792467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00792467.